 | | Friday, April 06, 2012 |  | | | |  |
Reduce Risk and Maximize Potential in Ophthalmology Development
Ophthalmic study design and execution can be quite different than other therapeutic areas. Pharm-Olam's team has a proven track record of excellence in achieving trial objectives and can provide strategic, operational and consulting to sponsors for phase I to phase IV development.
The majority of our clinical staff in emerging markets are MDs or PhDs, including Ophthalmologists in strategic areas for clinical trials. The incidence of disorders and standards of treatment can vary widely, so let Pharm-Olam conduct a complimentary feasibility study specific to your protocol and study budgets to use in your resource planning.
Contact us at www.pharm-olam.com, info@pharm-olam.com, USA 1-713-559-7900, UK 44-0-1344-891121. | | | | | 
Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing
This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set.
Request Now! | | | 
2012 Workshop on Protein Aggregation and Immunogenicity
July 9-12, 2012
Early Registration: $695 - $1,395
Aggregation of therapeutic proteins can occur during bioprocessing, shipping, storage and even delivery to the patient. Understanding of the roles of aggregates in immunogenicity of therapeutic protein products is critical. Such immune responses can have serious consequences for patients. Also, immunogenicity can be major stumbling blocks to product development and has even plagued licensed protein therapeutics. To increase understanding of the impact of protein aggregation on immunogenicity, the Workshop will focus on five central areas:
1) clinical aspects of immunogenicity to therapeutic proteins;
2) utility of animal models and in vitro cell assays for assessing immunogenicity of aggregates and particles;
3) causes and control of aggregates and particles in formulations;
4) causes and control of aggregates and particles during processing; and
5) insights and challenges with analytical methods.
Please note: The early registration fee expires May 1, 2012, and includes a buffet for breakfast and lunch each day, opening and closing receptions, and a workshop notebook.
To register and view the schedule of speakers by industry leader's visit our website. | | 
Biomarkers in Late Stage Clinical Trials
• Quantify and analyze revenues of late stage biomarker technology and services in North America, Europe, Asia and the Rest of the World.
• Identify the key market drivers and resistors of the biomarker market and evaluate the growth potential of emerging technologies.
• Assess biomarker activity at leading companies, including Abbott, AZ, BMS, Eli Lilly, GSK, Merck & Co, Novartis, Pfizer, Roche and Sanofi-Aventis.
Click Here for More Information. |  | |  • Pharm Country (Bedminster, New Jersey)
Allergan Inc.
Systems Development Manager, Clinical Programming
Manage the design, development, validation, implementation, maintenance and support of electronic systems, programs, scripts and tools for clinical trial data capture (e.g., EDC Oracle Inform, IVRS, ePRO), data integration (e.g. ETL Informatica PowerCenter, SOA, PL/SQL, Oracle, Clinical Data Repository) and reporting/delivery (Business Objects, Spotfire, Sharepoint, Infopath, SDTM).
• Genetown (Decentralized, Massachusetts)
PAREXEL International
Associate Director Clinical Research Operations
Partner with various functional groups to identify business processes, gather business requirements, and liaise with technical teams to ensure successful ERP implementation. Provide technical & operational leadership and consultation, stakeholder management, and project management for technical aspects supporting upgrades and migrations to our new ERP systems.
• BioCapital (Wilmington, Delaware)
AstraZeneca Pharmaceuticals LP
Statistical Science Director, Clinical Science
The main roles undertaken by the Statistical Science Director are Global Product Statistician (GPS), Statistical Expert or Delivery Team Leader. Statistical Science Directors provide highly experienced strategic, statistical support and leadership to product teams, specialised areas (e.g. patient safety, clinical pharmacology alliance, personalised healthcare), and the Statistics & Programming Department, in the creation of clinical development programmes to maximise the market potential of AstraZeneca products
• Biotech Beach (San Diego, California)
Ceregene, Inc.
Clinical Operations Associate
Responsible for various in-house activities related to clinical data managed by a contract research organization (CRO). Initiates manual queries of CRO and Ceregene databases and reviews for correct data values. Investigates and resolves incorrect data values with CRO contact.
• Biotech Bay (Santa Rosa, California)
On Assignment Clinical Research
Clinical Research Specialist
Works closely with the study manager to satisfy applicable clinical and regulatory requirements and internal requirements for clinical studies. This role focuses on assigned areas of clinical study management and provides support for clinical deliverables required in the Product Commercialization Process This role may perform some site training and co-monitoring.
• Get Noticed! Add your resume to the BioSpace Career Center!
• See more than 5,000 job postings in the BioSpace Career Center! | | 
Biotech Beach Career Fair
Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Southern California area.
Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)
Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.
Job seekers may register here.
• Biotech Beach Career Fair, La Jolla, CA April 17, 2012
• BioCapital Career Fair, Bethesda, MD April 25, 2012
• Pharm Country Career Fair, King Of Prussia, PA May 1, 2012
• BioNC Career Fair, Durham, NC May 2, 2012
• Biotech Bay Career Fair, Burlingame, CA May 29, 2012
More information about BioSpace's Career Fairs
BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services | | | | | | 
Hot Company
Gentris Corporation
133 Southcenter Court, Suite 400
Morrisville, North Carolina 27560 U.S.A.
Phone: 919-465-0100 Fax: 919-465-0554
Gentris Corporation is a leading global provider of applied clinical pharmacogenomic services. As pioneers in the field of pharmacogenomics, Gentris assists pharmaceutical companies and clinical research organizations to effectively integrate pharmacogenomics into their drug development programs to deliver safer, more effective drugs to market more quickly.
More Company Profiles | | 
Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship
ClinicaSpace
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
| ClinicaSpace
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217 |
Send questions and comments to the ClinicaSpace News Beat Team.
Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong
ClinicaSpace.com - Clinical Trials. Clinical Research. Community. | |  • ClinicaSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2012 ClinicaSpace http://www.clinicaspace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. | |  | |  |  | |
No comments:
Post a Comment